3-7487868-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000844.4(GRM7):​c.1515+26146C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.449 in 151,966 control chromosomes in the GnomAD database, including 15,749 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 15749 hom., cov: 32)

Consequence

GRM7
NM_000844.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.21

Publications

24 publications found
Variant links:
Genes affected
GRM7 (HGNC:4599): (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
GRM7 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.678 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000844.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
NM_000844.4
MANE Select
c.1515+26146C>T
intron
N/ANP_000835.1
GRM7
NM_181874.3
c.1515+26146C>T
intron
N/ANP_870989.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
ENST00000357716.9
TSL:1 MANE Select
c.1515+26146C>T
intron
N/AENSP00000350348.4
GRM7
ENST00000389336.8
TSL:1
c.1515+26146C>T
intron
N/AENSP00000373987.4
GRM7
ENST00000389335.7
TSL:1
n.1515+26146C>T
intron
N/AENSP00000373986.3

Frequencies

GnomAD3 genomes
AF:
0.449
AC:
68227
AN:
151848
Hom.:
15744
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.399
Gnomad AMI
AF:
0.414
Gnomad AMR
AF:
0.475
Gnomad ASJ
AF:
0.400
Gnomad EAS
AF:
0.697
Gnomad SAS
AF:
0.361
Gnomad FIN
AF:
0.571
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.446
Gnomad OTH
AF:
0.440
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.449
AC:
68271
AN:
151966
Hom.:
15749
Cov.:
32
AF XY:
0.454
AC XY:
33701
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.399
AC:
16563
AN:
41490
American (AMR)
AF:
0.475
AC:
7246
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.400
AC:
1386
AN:
3468
East Asian (EAS)
AF:
0.697
AC:
3567
AN:
5118
South Asian (SAS)
AF:
0.361
AC:
1737
AN:
4812
European-Finnish (FIN)
AF:
0.571
AC:
6033
AN:
10568
Middle Eastern (MID)
AF:
0.432
AC:
126
AN:
292
European-Non Finnish (NFE)
AF:
0.446
AC:
30312
AN:
67944
Other (OTH)
AF:
0.438
AC:
924
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1916
3832
5747
7663
9579
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
622
1244
1866
2488
3110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.444
Hom.:
48104
Bravo
AF:
0.444
Asia WGS
AF:
0.511
AC:
1776
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
1.8
DANN
Benign
0.29
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9870680; hg19: chr3-7529555; API